163 related articles for article (PubMed ID: 27595116)
21. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
22. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
23. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
[TBL] [Abstract][Full Text] [Related]
24. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
[TBL] [Abstract][Full Text] [Related]
25. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
26. Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy.
Ma W; Zhang T; Pan J; Shi N; Fan Q; Wang L; Lu SH
Oncol Rep; 2014 Oct; 32(4):1601-9. PubMed ID: 25175038
[TBL] [Abstract][Full Text] [Related]
27. Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer.
Xie Y; Dong CD; Wu Q; Jiang Y; Yao K; Zhang J; Zhao S; Ren Y; Yuan Q; Chen X; Liu Z; Zhao J; Liu K
Mol Carcinog; 2020 Feb; 59(2):215-226. PubMed ID: 31793679
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
[TBL] [Abstract][Full Text] [Related]
30. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
31. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
34. The Mammalian Target of Rapamycin-70-kDa Ribosomal Protein S6 Kinase Axis Inhibits the Biological Function of Tongue Squamous Cell Carcinoma.
Yi C; Huang Z; Huang Z; Zhao X; Li H; Wang J
J Oral Maxillofac Surg; 2019 Sep; 77(9):1928-1940. PubMed ID: 30339792
[TBL] [Abstract][Full Text] [Related]
35. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice.
Tian F; Zhang C; Tian W; Jiang Y; Zhang X
Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693
[TBL] [Abstract][Full Text] [Related]
37. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
39. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
